Correlation analysis between prenatal exposure of per-/polyfluoroalkyl compounds and neonatal outcome.
10.3760/cma.j.cn112150-20220503-00435
- Author:
Chen Ye XU
1
;
Wei Tong LI
1
;
Yong Hong TIAN
2
Author Information
1. College of Environmental and Engineering, Donghua University, Shanghai 201620, China.
2. Women's Hospital School of Medicine Zhejiang University, Hangzhou 310006, China.
- Publication Type:Journal Article
- MeSH:
Pregnancy;
Infant, Newborn;
Female;
Humans;
Adult;
Birth Weight;
Prenatal Exposure Delayed Effects;
Alkanesulfonic Acids/analysis*;
Alkanesulfonates/analysis*;
Fluorocarbons/analysis*;
Ethers/analysis*;
Ethyl Ethers/analysis*;
Environmental Pollutants/analysis*;
Maternal Exposure
- From:
Chinese Journal of Preventive Medicine
2023;57(3):362-370
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the correlation between the prenatal exposure of per-/polyfluoroalkyl substances (PFASs) and the neonatal outcome. Methods: A total of 506 maternal infant cohort samples were collected in Hangzhou, Zhejiang province from 2020 to 2021. The exposure levels of seven PFASs in maternal serum before delivery were detected by solid-phase extraction-ultra performance liquid chromatography tandem mass spectrometry. Multivariable linear regression model was used to analyze the influence of prenatal exposure of PFASs on birth weight, birth length and Apgar score. Results: The maternal age, prenatal body mass index and gestation age were (31.3±4.3) years old, (26.7±3.2) kg/m2 and (265.0±28.3) days, respectively. The birth weight, birth length and scores of Apgar-1 and Apgar-5 were (3.1±0.8) kg, (49.3±2.9) cm, (9.88±0.47) points and (9.99±0.13) points, respectively. PFASs were widely distributed in maternal serum, with the highest concentration of (18.453±19.557) ng/ml, (6.756±9.379) ng/ml and (5.057±8.555) ng/ml for perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS) and 6∶2 chlorinated polyfluorinated ether sulfonate (Cl-PFESA), respectively. Maternal age, parity and delivery mode were associated with the exposure level of PFASs (P<0.05). Subgroup analysis showed that PFOS had negative effects on birth weight (β=-0.958), birth length (β=-0.073) and Apgar-5 score (β=-0.288) for neonates in the low birth weight (LBW) group. 6∶2 Cl-PFESA and 8∶2 Cl-PFESA inhibited the birth weight (β=-0.926; β=-0.552) and length (β=-0.074; β=-0.045) of newborn in the LBW group. In addition, 4∶2 fluorotelomer sulfonate (FTS) was associated with increased birth weight (β=0.111) and decreased Apgar-5 score (β=-0.030) in the normal weight group. Conclusion: Prenatal exposure to PFASs is associated with birth weight, birth length and Apgar-5 score. It is necessary to continue to pay attention to the impact of PFASs on fetal growth and development through maternal-fetal transmission.
